Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 SGD | -8.33% | +10.00% | -31.25% |
Apr. 29 | Clearbridge Health Awards Shares Under Performance Share Plan | MT |
Feb. 29 | Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 16.41M 12.2M | Sales 2023 | 11.49M 8.54M | Capitalization | 9.9M 7.36M |
---|---|---|---|---|---|
Net income 2022 | -11M -8.18M | Net income 2023 | -32M -23.78M | EV / Sales 2022 | 1.49 x |
Net Debt 2022 | 913K 679K | Net Debt 2023 | 2.5M 1.86M | EV / Sales 2023 | 1.08 x |
P/E ratio 2022 |
-2.11
x | P/E ratio 2023 |
-0.31
x | Employees | 121 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.05% |
1 day | -8.33% | ||
1 week | +10.00% | ||
Current month | +10.00% | ||
1 month | -8.33% | ||
3 months | -15.38% | ||
6 months | -15.38% | ||
Current year | -31.25% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Wei Chee Tan
AUD | Comptroller/Controller/Auditor | 39 | 22-09-30 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 22-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Mark Ryan
BRD | Director/Board Member | 57 | 17-11-19 |
Andrew Lord
BRD | Director/Board Member | 65 | 17-11-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.011 | -8.33% | 812,500 |
24-05-16 | 0.012 | 0.00% | 100 |
24-05-15 | 0.012 | +20.00% | 13,367,400 |
24-05-14 | 0.01 | 0.00% | 656,000 |
24-05-13 | 0.01 | 0.00% | 1,159,000 |
Delayed Quote Singapore S.E., May 17, 2024 at 03:47 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-31.25% | 5.53M | |
+19.28% | 84.52B | |
-26.95% | 72.21B | |
+4.65% | 27.74B | |
-7.35% | 17.97B | |
-0.46% | 17.46B | |
+4.69% | 15.82B | |
+8.14% | 13.55B | |
+6.59% | 13.31B | |
+70.00% | 12.5B |
- Stock Market
- Equities
- 1H3 Stock